Aydan Usman

491 total citations
28 papers, 384 citations indexed

About

Aydan Usman is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Endocrine and Autonomic Systems. According to data from OpenAlex, Aydan Usman has authored 28 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Epidemiology and 5 papers in Endocrine and Autonomic Systems. Recurrent topics in Aydan Usman's work include Adipokines, Inflammation, and Metabolic Diseases (9 papers), Thyroid Disorders and Treatments (7 papers) and Regulation of Appetite and Obesity (5 papers). Aydan Usman is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (9 papers), Thyroid Disorders and Treatments (7 papers) and Regulation of Appetite and Obesity (5 papers). Aydan Usman collaborates with scholars based in Türkiye, Russia and United States. Aydan Usman's co-authors include Neşe Ersöz Gülçelik, Alper Gürlek, Jale Karakaya, Meltem Halil, Servet Arıoğul, Neşe Çınar, Şafak Akın, Kadriye Aydın, Figen Kaymaz and Naciye Dilara Zeybek and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Endocrinology and Clinical Endocrinology.

In The Last Decade

Aydan Usman

27 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aydan Usman Türkiye 10 158 113 105 79 57 28 384
Naoufel Nabli Tunisia 12 126 0.8× 78 0.7× 105 1.0× 87 1.1× 41 0.7× 27 345
K. Tsuchihashi Japan 6 194 1.2× 134 1.2× 121 1.2× 69 0.9× 116 2.0× 9 442
Deborah K. Oh United States 6 218 1.4× 165 1.5× 134 1.3× 64 0.8× 95 1.7× 11 456
Dalia El-Lebedy Egypt 12 86 0.5× 91 0.8× 95 0.9× 45 0.6× 98 1.7× 29 453
Sezin Bingöl Türkiye 9 173 1.1× 83 0.7× 87 0.8× 67 0.8× 54 0.9× 11 392
Anna Stępień Poland 10 112 0.7× 79 0.7× 59 0.6× 40 0.5× 116 2.0× 24 432
Kawtar Raghay Spain 9 240 1.5× 207 1.8× 57 0.5× 121 1.5× 73 1.3× 10 448
Toshihiko Hashinaga Japan 10 283 1.8× 184 1.6× 119 1.1× 48 0.6× 168 2.9× 13 511
Crystal M. Ghantous Lebanon 7 134 0.8× 110 1.0× 41 0.4× 70 0.9× 84 1.5× 11 349
Maria Cristina Procopio Italy 8 161 1.0× 92 0.8× 92 0.9× 37 0.5× 127 2.2× 15 393

Countries citing papers authored by Aydan Usman

Since Specialization
Citations

This map shows the geographic impact of Aydan Usman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aydan Usman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aydan Usman more than expected).

Fields of papers citing papers by Aydan Usman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aydan Usman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aydan Usman. The network helps show where Aydan Usman may publish in the future.

Co-authorship network of co-authors of Aydan Usman

This figure shows the co-authorship network connecting the top 25 collaborators of Aydan Usman. A scholar is included among the top collaborators of Aydan Usman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aydan Usman. Aydan Usman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Usman, Aydan, et al.. (2025). Advances in Non-statin Lipid Therapies: A Narrative Review of Evolving Strategies for Cardiovascular Risk Reduction. American Journal of Cardiovascular Drugs. 26(1). 35–57.
2.
Gülçelik, Neşe Ersöz, et al.. (2022). The role of vascular endothelial growth factor in the development of papillary thyroid carcinoma in patients with lymphocytic thyroiditis. Minerva Endocrinology. 48(4). 379–386. 2 indexed citations
3.
Aksu, Nalan Metin, et al.. (2020). Adiponectin levels decrease independently of body mass index and diabetes type after the normalization of hyperglycemia. TURKISH JOURNAL OF MEDICAL SCIENCES. 44(2). 312–315. 1 indexed citations
4.
Aydın, Kadriye, Neşe Ersöz Gülçelik, Murat Tuncel, et al.. (2019). Thyroid volumes and serum VEGF levels in dyslipidemic patients: effects of statin treatment. TURKISH JOURNAL OF MEDICAL SCIENCES. 49(3). 738–745. 7 indexed citations
5.
Akın, Şafak, et al.. (2017). Increased Serum Nesfatin-1 Levels in Patients with Impaired Glucose Tolerance. Endocrinology research and practice.. 21(3). 65–67. 3 indexed citations
7.
Özdemır, Didem, Selçuk Dağdelen, & Aydan Usman. (2013). Plasma Osteoprotegerin Levels Before and After Treatment of Thyroid Dysfunctions. SHILAP Revista de lepidopterología. 17(4). 102–107. 3 indexed citations
8.
Yıldız, Bülent Okan, Duygu Yazgan Aksoy, Ayla Harmancı, et al.. (2013). Effects of L-Thyroxine Therapy on Circulating Leptin and Adiponectin Levels in Subclinical Hypothyroidism: A Prospective Study. Archives of Medical Research. 44(4). 317–320. 11 indexed citations
9.
Canpolat, Uğur, Lâle Tokgözoğlu, Kadriye Aydın, et al.. (2012). Impaired aortic elastic properties in patients with adult-onset hypogonadism. Blood Pressure. 22(2). 114–119. 6 indexed citations
10.
Akın, Şafak, Duygu Yazgan Aksoy, Neşe Çınar, et al.. (2012). Pigment epithelium‐derived factor increases in type 2 diabetes after treatment with metformin. Clinical Endocrinology. 77(6). 852–856. 17 indexed citations
11.
Zeybek, Naciye Dilara, Neşe Ersöz Gülçelik, Figen Kaymaz, et al.. (2011). Rosuvastatin induces apoptosis in cultured human papillary thyroid cancer cells. Journal of Endocrinology. 210(1). 105–115. 40 indexed citations
12.
Gülçelik, Neşe Ersöz & Aydan Usman. (2010). Macroprolactinaemia in diabetic patients.. PubMed. 31(2). 270–4. 10 indexed citations
13.
Özdemir, Didem, Selçuk Dağdelen, & Aydan Usman. (2010). Thyroid dysfunction related abnormalities in adiponectin and glucose metabolism before and after treatment. AYBU AVESIS. 22. 1 indexed citations
14.
Gülçelik, Neşe Ersöz, Aydan Usman, & Alper Gürlek. (2009). Role of adipocytokines in predicting the development of diabetes and its late complications. Endocrine. 36(3). 397–403. 48 indexed citations
15.
Gülçelik, Neşe Ersöz, et al.. (2008). Serum vaspin levels in type 2 diabetic women in relation to microvascular complications. European Journal of Endocrinology. 160(1). 65–70. 85 indexed citations
16.
Bayraktar, Miyase, Aydan Usman, & Z. Koray. (1994). Effect of the new somatostatin analogue SMS 201-995 on exogenously used insulin. Journal of Molecular Medicine. 72(9). 669–672. 1 indexed citations
17.
Erbaş, Tomris, Aydan Usman, Belkıs Erbaş, et al.. (1993). Short-term effects of somatostatin analogue (SMS 201–995) on left ventricular function in healthy persons: A scintigraphic study. Journal of Endocrinological Investigation. 16(11). 857–861. 9 indexed citations
18.
Erbaş, Tomris, Belkıs Erbaş, Aydan Usman, & C F Bekdik. (1992). Assessment of Left Ventricular Dysfunction in Acromegalic Patients Using Radionuclide Ventriculography Parameters. Cardiology. 80(3-4). 172–179. 9 indexed citations
19.
Bayraktar, Miyase, et al.. (1990). THE EFFECT OF RADIOACTIVE IODINE TREATMENT ON THYROID C CELLS. Clinical Endocrinology. 33(5). 625–630. 13 indexed citations
20.
Usman, Aydan. (1983). Lack of effect of chronic hypocalcaemia on serum prolactin response to chlorpromazine. European Journal of Endocrinology. 103(3). 321–325. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026